Related Experiment Video
Updated: Apr 8, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.5K
[Molecular signatures of breast cancer: What clinical utility?]
Suzette Delaloge1, Mahasti Saghatchian2, Amal Ghouadni2
1Department of medical oncology, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U981, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France.
Bulletin Du Cancer
|June 30, 2015
Abstract:
The role of molecular signatures in the adjuvant management of breast cancer remains a debated topic. Discussions should take into account the level of scientific validation, the impact on practice, the expected benefits and financing issues. This article presents the key points for a rational use of commercial molecular signatures.
Keywords:
Breast cancerCancer du seinMolecular signaturesPredictionPrognosisPronosticPrédictionSignature moléculaire
